Biology Reference
In-Depth Information
46. Koszalka P, Ozuyaman, B, Huo Y, Zernecke A, Flogel U. Braun N, Buchheiser A, Decking
UK, Smith ML, Sevigny J, Gear A, Weber AA, Molojavyi A, Ding Z, Weber C, Ley
K, Zimmermann H, Godecke A, Schrader J. (2004) Targeted disruption of cd73/ecto-5 -
nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ
Res 95:814-21.
47. Koyama T, Oike M, Ito Y. (2001) Involvement of Rho-kinase and tyrosine kinase in hypotonic
stress-induced ATP release in bovine aortic endothelial cells J Physiol 532:759-69.
48. Krötz F, Sohn HY, Keller M, Gloe T, Bolz SS, Becker BF, Pohl U. (2002) Depolarization of
endothelial cells enhances platelet aggregation through oxidative inactivation of endothelial
NTPDase. Arterioscler Thromb Vasc Biol 22:2003-9.
49. Lazarowski ER, Homolya L, Boucher RC, Harden. (1997) TK Identification of an ecto-
nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists.
J Biol Chem 272:20402-7.
50. Lazarowski, ER, Boucher RC, Harden TK. (2003) Mechanisms of release of nucleotides and
integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol
64:785-95.
51. Lemoli RM, Ferrari D, Fogli M, Rossi L, Pizzirani C, Forchap S, Chiozzi P, Vaselli D,
Bertolini F, Foutz T, Aluigi M, Baccarani M, Di Virgilio F. (2004) Extracellular nucleotides
are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood
104:1662-70.
52. Liekens S, De Clercq E, Neyts, J. (2001) Angiogenesis: regulators and clinical applications.
Biochem Pharmacol 61:253-70.
53. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R.
(2003) Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-
nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 305:
9-16.
54. Mayer H, Bertram H. Lindenmaier W, Korff T. Weber, H, Weich H. (2005) Vascular endothe-
lial growth factor. (VEGF-A) expression in human mesenchymal stem cells: autocrine and
paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827-39.
55. Meghji P, Pearson JD, Slakey LL. (1995) Kinetics of extracellular ATP hydrolysis by
microvascular endothelial cells from rat heart. Biochem J 308:725-31.
56. Meyrick B. (2001) The pathology of pulmonary artery hypertension. Clin Chest Med 22:
393-404, vii.
57. Mizumoto N, Kumamoto T, Robson SC, Sévigny J, Matsue H, Enjyoji K, Takashima A.
(2002) CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles
in inflammation and immune responsiveness. Nat Med 8:358-65.
58. Moreno PR, Fuster V. (2004) New aspects in the pathogenesis of diabetic atherothrombosis.
J Am Coll Cardiol 44:2293-300.
59. Motte S, Pirroton S, Boeynaems JM. (1993) Heterogeneity of ATP receptors in aortic endothe-
lial cells. Involvement of P2y and P2u receptors in inositol phosphate response. Circ Res
72:504-10.
60. Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM,
Gillies S, Javaherian K, Folkman J. (2003) Inhibition of plaque neovascularization reduces
macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci
USA 100:4736-41.
61. Mitzner W, Wagner EM. (2004) Vascular remodeling in the circulations of the lung. J Appl
Physiol 97:1999-2004.
62. Noll T, Hölschermann H, Koprek K, Gündüz D, Haberbosch W, Tillmanns H, Piper
HM. (1999) ATP reduces macromolecule permeability of endothelial monolayers despite
increasing [Ca 2+ ]. Am J Physiol 276:H1892-1901.
63. Novak I. (2003) ATP as a signaling molecule: the exocrine focus. News Physiol Sci 18:12-7.
64. Numano F. (2000) Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75(Suppl 1):S1-
S8; discussion S17-S19.
Search WWH ::




Custom Search